Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2009
10/14/2009CN100548322C An anti-tumor pharmaceutical composition and preparation method thereof
10/14/2009CN100548314C Snake venom cytotoxin, preparation method and application thereof
10/14/2009CN100548311C Application of sodium thiosulfate in the preparation of clinical selenium-complementing and cancer-treating medicine and fast- preparing method for the same
10/14/2009CN100548296C Mitotic kinesin inhibitors
10/14/2009CN100548284C Microemulsion of hypocrellin, and its preparing method
10/14/2009CN100548282C Medicine for treating liver cancer
10/14/2009CN100548274C Water type injection containing paclitaxel and its preparing method
10/14/2009CN100548193C Peony massage pillow and its manufacture method
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601813 Anti-GL50 antibodies
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601801 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine
10/13/2009US7601748 Anti-androgenic pyrrolidines with tumor-inhibiting action
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601724 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
10/13/2009US7601703 Complexing the target cell with therapeutic agent; antiproliferative agent
10/13/2009US7601359 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins
10/13/2009US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/13/2009US7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA
10/13/2009US7601349 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
10/13/2009US7601344 Von Hippel-Lindau (VHL) gene in cancer cells which express neuropeptide Y, neurofilament, and microtubule associated protein 2; plasmids; Parkinson's disease, amyotrophic lateral sclerosis, Huntington's chorea, Alzheimer's disease, brain infarction, spinal cord injury, brain contusion or malignant tumor
10/13/2009US7601343 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides
10/13/2009CA2521846C Reverse-turn mimetics and method relating thereto
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2470484C A combination comprising combretastatin and anticancer agents
10/13/2009CA2428160C Compositions for antitumor treatment containing ecteinascidin 743
10/13/2009CA2370830C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
10/13/2009CA2368274C C10 ester substituted taxanes as antitumor agents
10/13/2009CA2356331C Methods for glucagon suppression
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/13/2009CA2292775C Cyanoguanidines as cell proliferation inhibitors
10/13/2009CA2291218C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/13/2009CA2236888C Medicament, in particular for modulation of the immune response in the control of viruses, tumors, bacteria and parasites
10/13/2009CA2234263C Pharmaceutical composition for treating papillomavirus tumours and infection
10/13/2009CA2154488C Ganglioside-klh conjugate vaccines with qs-21
10/13/2009CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/08/2009WO2009124259A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
10/08/2009WO2009124237A1 Halichondrin b analogs
10/08/2009WO2009124184A2 Methods of activating rnase l
10/08/2009WO2009124103A2 Combination therapies comprising par1 antagonists with par4 antagonists
10/08/2009WO2009124037A1 Processes for preparing sunitinib and salts thereof
10/08/2009WO2009124024A1 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/08/2009WO2009124013A1 Compositions and mehtods for inhibition of hepatocyte growth factory receptor c-met signaling
10/08/2009WO2009123986A1 Apoptosis signal-regulating kinase 1 inhibitors
10/08/2009WO2009123971A1 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
10/08/2009WO2009123934A2 Branched multifunctional nanoparticle conjugates and their use
10/08/2009WO2009123881A1 Purine derivatives as a3 receptor- selective agonists
10/08/2009WO2009123588A1 Amides of 3, 5-substituted-is0xaz0le-4-carb0xylic acids for the treatment of viral infections, cancer and restenosis
10/08/2009WO2009123481A1 Compositions and methods for treatment of neoplastic disease
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123188A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009WO2009123145A1 Parasporin-1 receptor and use thereof
10/08/2009WO2009122667A1 Therapeutic for hepatic cancer
10/08/2009WO2009122639A1 Abc transporter protein expression inhibitor
10/08/2009WO2009122288A2 Liquid and freeze dried formulations
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009122176A2 Rapamycin carbonate esters
10/08/2009WO2009122148A1 Fused thiophene and thiazole derivatives as pi3k kinase inhibitors
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009WO2009121939A2 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009WO2009121910A1 Indene derivatives as estrogen receptor ligands
10/08/2009WO2009121631A2 Nanoparticles for targeted delivery of active agents to the lung
10/08/2009WO2009121245A1 Fostriecin derivatives and the pharmaceutical uses thereof
10/08/2009WO2009121238A1 A composition and method for auto-treating tumors
10/08/2009WO2009121162A1 Assay for soluble cd200
10/08/2009WO2009100330A3 Platinum aggregates and process for producing the same
10/08/2009WO2009097351A9 TAK1-D MEDIATED INDUCTION OF CELL DEATH IN HUMAN CANCER CELLS BY SPECIFIC SEQUENCE SHORT DOUBLE STRANDED RNAs
10/08/2009WO2009088838A3 Triarylmethane analogs and their use in treating cancers
10/08/2009WO2009077874A3 A pharmaceutical composition for treating esophageal cancer
10/08/2009WO2009040045A3 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
10/08/2009WO2009033758A3 Use of the peptide phpfhffvyk as therapeutic agent
10/08/2009WO2007124849A3 Inhibitors of the task-1 and task-3 ion channel
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090253807 Aqueous suspension preparations
10/08/2009US20090253793 Composition and method for binding acetaldehyde in stomach
10/08/2009US20090253778 DNA composition against tumor stromal antigen FAP and methods of use thereof
10/08/2009US20090253775 Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis
10/08/2009US20090253770 Target gene mimitin of myc
10/08/2009US20090253769 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253738 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/08/2009US20090253736 Azaindole derivatives as cftr modulators
10/08/2009US20090253732 Production Of Polyketides And Other Natural Products
10/08/2009US20090253723 Protein kinase inhibitors
10/08/2009US20090253721 Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor
10/08/2009US20090253719 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/08/2009US20090253718 Pharmaceutical Compounds
10/08/2009US20090253717 Inhibitors of p97
10/08/2009US20090253715 Heteroaryl-containing isoflavones as aromatase inhibitors
10/08/2009US20090253709 Synthesis, telomerase inhibition and cytotoxic studies on 2,7-disubstituted anthraquinone derivatives
10/08/2009US20090253707 Heteroannelated anthraquinone derivatives and the synthesis method thereof
10/08/2009US20090253689 Organic Compounds
10/08/2009US20090253688 Semicarbazide derivatives as kinase inhibitors
10/08/2009US20090253686 Unsolvated benzodiazepine compositions and methods
10/08/2009US20090253685 Product comprising at least one Cdc25 phosphatase inhibitor in combination with at least one other anti-cancer agent
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009US20090253653 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/08/2009US20090253647 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
1 ... 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 ... 2211